調査レポートカテゴリー： MarketsandMarkets, 世界

Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024

ゲノミクスの世界市場予測（～2024年）

◆タイトル：Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024
◆商品コード：BT-2209
◆調査・発行会社：MarketsandMarkets
◆発行日：2019年3月25日
◆ページ数：195
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオテクノロジー
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,650 ⇒換算￥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥880,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

ゲノミクスの世界市場は、2019年の189億米ドルから2024年には357億米ドルに達し、この期間中13.5％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、政府の援助資金の増加、ゲノミクスプロジェクトの増加、シーケンスコストの削減、ゲノミクスの応用分野の拡大、ゲノミクス分野への企業の新規参入などが考えられます。一方で、ゲノム関連機器の高コストは市場の成長を抑制する主な要因です。当調査レポートでは、ゲノミクスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品・サービス（システム・ソフトウェア、消耗品、サービス）分析、技術（シーケンシング、マイクロアレイ、PCR）分析、用途（診断、精密医療）分析、エンドユーザー（研究所）分析、ゲノミクスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Genomics market is projected to grow at a CAGR of 13.5% during the forecast period”The global genomics market is projected to reach USD 35.7 billion by 2024 from USD 18.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Factors such as the rising government funding and growth in the number of genomics projects, decreasing sequencing costs, growing application areas of genomics, and the entry of new players and start-ups in the genomics field are driving the growth of the genomics market. However, the high cost of genomic equipment is one of the major factors restraining the growth of this market.

“The services segment is projected to grow at the highest CAGR during the forecast period”
Based on product & service, the genomics market is segmented into consumables, systems & software, and services. During the forecast period, the services segment is expected to grow at the highest CAGR majorly due to the increasing awareness of genomics and the reducing cost of DNA sequencing.

“Diagnostic applications to grow at the highest CAGR during the forecast period”
Based on application, the genomics market is segmented into diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and other applications. During the forecast period, the diagnostic applications segment is projected to grow at the highest CAGR majorly due to the increasing awareness of genomics among patients and the improving efficiency of genomic sequencing in the diagnosis of diseases.

“In the end-user market, the hospitals and clinics segment is estimated to witness the highest growth during the forecast period”
Based on end user, the genomics market is segmented into research centers and academic & government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users. During the forecast period, the hospitals and clinics segment is estimated to grow at the highest CAGR owing to the growing availability of genetic tests and pharmacogenomics and the rising emphasis on providing personalized medicine in hospitals.

“Growing investments and favorable government initiatives for genomics research to offer growth opportunities in North America during the forecast period”

During the forecast period, the North American market is estimated to witness high growth owing to factors such as the implementation of favorable initiatives by governments in the US and Canada and rising investments in the pharmaceutical, biotechnology, medical, and academic research sectors in these countries.

Breakdown of supply-side primary interviews:

• By Company Type – Tier I: 55%, Tier II: 25%, and Tier III: 20%
• By Designation – C-level: 43%, Director-level: 32%, and Others: 25%
• By Region – North America: 38%, Europe: 23%, Asia Pacific: 29%, and RoW: 10%

QIAGEN (Netherlands), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Agilent Technologies (US), Illumina (US), Pacific Biosciences of California (US), Eurofins Scientific (Germany), BGI (China), GE Healthcare (UK), F. Hoffmann-La Roche (Switzerland), Oxford Nanopore Technologies (UK), and Eppendorf (Germany) are the major players operating in this market.
Research coverage:
This report studies the genomics market based on product and service, application, end user, and region. It also includes an analysis of factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key benefits of buying the report
This report focuses on various levels of analysis—industry trends, the market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the genomics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 22
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 23
2.1.2.1 Key data from primary sources 25
2.1.2.2 Key industry insights 26
2.2 MARKET SIZE ESTIMATION 26
2.2.1 MARKET DATA VALIDATION AND TRIANGULATION 28
2.3 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 35
4.1 GENOMICS: MARKET OVERVIEW 35
4.2 NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2018 36
4.3 ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018 37
4.4 GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET 38
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
5.2.1 DRIVERS 40
5.2.1.1 Rising government funding and growth in the number of genomics projects 40
5.2.1.2 Decreasing sequencing costs 41
5.2.1.3 Growing application areas of genomics 41
5.2.1.4 Entry of new players and start-ups in the genomics market 42
 
5.2.2 RESTRAINTS 42
5.2.2.1 High cost of genomic equipment 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 Use of genomics in specialized/personalized medicine 43
5.2.4 CHALLENGES 43
5.2.4.1 Dearth of trained professionals 43
5.2.4.2 Secure storage of large volumes of sequenced data 44
6 GENOMICS MARKET, BY PRODUCT AND SERVICE 45
6.1 INTRODUCTION 46
6.2 CONSUMABLES 47
6.2.1 CONSUMABLES FORMS THE LARGEST SEGMENT OF THE GENOMICS MARKET 47
6.3 SYSTEMS & SOFTWARE 48
6.3.1 WITH GENOME SEQUENCING AVAILABLE AT SUBSTANTIALLY LOWER RATES, THE DEMAND FOR SYSTEMS & SOFTWARE IS EXPECTED TO INCREASE 48
6.4 SERVICES 51
6.4.1 THE SERVICES SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 51
7 GENOMICS MARKET, BY TECHNOLOGY 53
7.1 INTRODUCTION 54
7.2 PCR 55
7.2.1 PCR ALLOWS RESEARCHERS TO PRODUCE MILLIONS OF COPIES OF A SPECIFIC DNA SEQUENCE WITHIN HOURS 55
7.3 SEQUENCING 56
7.3.1 INCREASING APPLICATIONS OF SEQUENCING IN ANIMAL BREEDING, AGRICULTURE, AND HUMAN GENOMICS TO DRIVE MARKET GROWTH 56
7.4 MICROARRAY 57
7.4.1 MICROARRAY TECHNOLOGIES ARE WIDELY USED IN THE FIELD OF GENOMICS DUE TO THEIR LOW COST 57
7.5 NUCLEIC ACID EXTRACTION AND PURIFICATION 59
7.5.1 ADVANCES IN NUCLEIC ACID EXTRACTION AND PURIFICATION TECHNOLOGIES ARE EXPECTED TO SUPPORT THE GROWTH OF THIS MARKET 59
7.6 OTHER TECHNOLOGIES 60
8 GENOMICS MARKET, BY APPLICATION 62
8.1 INTRODUCTION 63
8.2 DIAGNOSTICS 64
8.2.1 DIAGNOSTICS FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE GENOMICS MARKET 64
8.3 DRUG DISCOVERY AND DEVELOPMENT 67
8.3.1 GROWING APPLICATION OF GENOMICS IN THE AREA OF DRUG DISCOVERY AND DEVELOPMENT TO PROPEL MARKET GROWTH 67
 
8.4 PRECISION MEDICINE 69
8.4.1 PRECISION MEDICINE FOCUSES ON IDENTIFYING THE MOST EFFECTIVE MEDICAL TREATMENTS FOR PATIENTS BASED ON THEIR GENETIC, ENVIRONMENTAL, AND LIFESTYLE FACTORS 69
8.5 AGRICULTURE & ANIMAL RESEARCH 70
8.5.1 GENOMICS HELPS IN IMPROVING THE PRODUCTIVITY OF CROPS AND LIVESTOCK 70
8.6 OTHER APPLICATIONS 71
9 GENOMICS MARKET, BY END USER 73
9.1 INTRODUCTION 74
9.2 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 75
9.2.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF GENOMICS SYSTEMS AMONG ACADEMIC & GOVERNMENT INSTITUTES 75
9.3 HOSPITALS & CLINICS 77
9.3.1 INCREASING DEMAND FOR PHARMACOGENOMICS TO DRIVE THE ACCEPTANCE OF NGS IN HOSPITALS 77
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 78
9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE THE USE OF GENOMIC SYSTEMS AND SERVICES AMONG PHARMA & BIOTECH COMPANIES 78
9.5 OTHER END USERS 80
10 GENOMICS MARKET, BY REGION 82
10.1 INTRODUCTION 83
10.2 NORTH AMERICA 85
10.2.1 US 88
10.2.1.1 US dominates the North American genomics market due to the increasing research funding and government initiatives for promoting precision medicine and the use of GM crops 88
10.2.2 CANADA 91
10.2.2.1 Increasing research in the field of genomics to drive market growth 91
10.3 EUROPE 94
10.3.1 UK 96
10.3.1.1 UK to register the highest CAGR in the European genomics market during the forecast period 96
10.3.2 GERMANY 99
10.3.2.1 Availability of funding for life sciences research to boost market growth in Germany 99
10.3.3 FRANCE 101
10.3.3.1 Increasing government investments in genomics to boost the growth of the French genomics market 101
10.3.4 ROE 103
 
10.4 ASIA PACIFIC 105
10.4.1 CHINA 108
10.4.1.1 China is expected to command the largest share of the Asia Pacific market 108
10.4.2 INDIA 110
10.4.2.1 Emergence of local players is expected to aid the growth of the genomics market in India 110
10.4.3 JAPAN 113
10.4.3.1 Increasing government focus on cancer research in Japan to increase demand for genomics products 113
10.4.4 REST OF ASIA PACIFIC 115
10.5 REST OF THE WORLD 118
10.5.1 MIDDLE EAST AND AFRICA 120
10.5.1.1 Increasing adoption of genetic testing in the Middle East and rising HIV & cancer incidence in Africa are driving market growth 120
10.5.2 LATIN AMERICA 123
10.5.2.1 Government funding and partnerships to boost the adoption of genomics products and services in Latin America 123
11 COMPETITIVE LANDSCAPE 126
11.1 OVERVIEW 126
11.1.1 THERMO FISHER SCIENTIFIC 126
11.1.2 ILLUMINA 127
11.1.3 QIAGEN 127
11.1.4 OTHERS 128
11.2 COMPETITIVE SCENARIO 128
11.2.1 PRODUCT LAUNCHES AND APPROVALS 128
11.2.2 EXPANSIONS 128
11.2.3 AGREEMENTS AND COLLABORATIONS 129
11.2.4 ACQUISITIONS 129
11.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2018) 130
11.3.1 VISIONARY LEADERS 130
11.3.2 INNOVATORS 130
11.3.3 DYNAMIC DIFFERENTIATORS 130
11.3.4 EMERGING COMPANIES 130
11.4 COMPETITIVE BENCHMARKING 132
11.4.1 ANALYSIS OF THE PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE GENOMICS MARKET (25 COMPANIES) 132
11.4.2 BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE GENOMICS MARKET (25 COMPANIES) 133
 
11.5 COMPETITIVE LEADERSHIP MAPPING (START-UP) (2018) 134
11.5.1 PROGRESSIVE COMPANIES 134
11.5.2 STARTING BLOCKS 134
11.5.3 DYNAMIC COMPANIES 134
11.5.4 RESPONSIVE COMPANIES 134
12 COMPANY PROFILES 136
(Business Overview, Products Offered, Service Offered Recent Developments, MnM View)*
12.1 ILLUMINA, INC. 136
12.2 THERMO FISHER SCIENTIFIC 143
12.3 QIAGEN 148
12.4 EUROFINS SCIENTIFIC 154
12.5 AGILENT TECHNOLOGIES 157
12.6 OXFORD NANOPORE TECHNOLOGIES 163
12.7 F. HOFFMANN-LA ROCHE 165
12.8 BIO-RAD LABORATORIES 169
12.9 BGI 172
12.10 DANAHER CORPORATION 176
12.11 GE HEALTHCARE 179
12.12 EPPENDORF 183
*Business Overview, Products Offered, Service Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 185
13.1 DISCUSSION GUIDE 185
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 190
13.3 AVAILABLE CUSTOMIZATIONS 192
13.4 RELATED REPORTS 192
13.5 AUTHOR DETAILS 194

LIST OF TABLES

TABLE 1 GENOMICS MARKET, BY PRODUCT AND SERVICE, 2017–2024 (USD MILLION) 46
TABLE 2 GENOMICS MARKET FOR CONSUMABLES, BY COUNTRY,
2017–2024 (USD MILLION) 48
TABLE 3 GENOMICS MARKET FOR SYSTEMS/SOFTWARE, BY COUNTRY,
2017–2024 (USD MILLION) 50
TABLE 4 GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2017–2024 (USD MILLION) 52
TABLE 5 GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 54
TABLE 6 GENOMICS MARKET FOR PCR, BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 7 GENOMICS MARKET FOR SEQUENCING, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 8 GENOMICS MARKET FOR MICROARRAY, BY COUNTRY, 2017–2024 (USD MILLION) 58
TABLE 9 GENOMICS MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION,
BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 10 GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY,
2017–2024 (USD MILLION) 61
TABLE 11 GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 64
TABLE 12 GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION) 65
TABLE 13 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT,
BY COUNTRY, 2017–2024 (USD MILLION) 68
TABLE 14 GENOMICS MARKET FOR PRECISION MEDICINE, BY COUNTRY,
2017–2024 (USD MILLION) 69
TABLE 15 GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,
BY COUNTRY, 2017–2024 (USD MILLION) 70
TABLE 16 GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2017–2024 (USD MILLION) 72
TABLE 17 GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 74
TABLE 18 GENOMICS MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION) 76
TABLE 19 GENOMICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2017–2024 (USD MILLION) 78
TABLE 20 GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,
BY COUNTRY, 2017–2024 (USD MILLION) 79
TABLE 21 GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY,
2017–2024 (USD MILLION) 81
TABLE 22 GENOMICS MARKET, BY REGION, 2017–2024 (USD MILLION) 84
TABLE 23 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 86
TABLE 24 NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 86
TABLE 25 NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 86
TABLE 26 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 87
TABLE 27 NORTH AMERICA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 87
TABLE 28 US: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 89
TABLE 29 US: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 89
TABLE 30 US: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 90
TABLE 31 US: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 90
TABLE 32 INDICATIVE LIST OF PROJECTS FUNDED BY GAPP IN 2018 91
TABLE 33 CANADA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 92
TABLE 34 CANADA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 92
TABLE 35 0CANADA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 93
TABLE 36 CANADA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 93
TABLE 37 EUROPE: GENOMICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 95
TABLE 38 EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 95
TABLE 39 EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 95
TABLE 40 EUROPE: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 96
TABLE 41 EUROPE: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 96
TABLE 42 UK: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 97
TABLE 43 UK: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 98
TABLE 44 UK: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 98
TABLE 45 UK: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 98
TABLE 46 GERMANY: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 99
TABLE 47 GERMANY: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 100
TABLE 48 GERMANY: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 100
TABLE 49 GERMANY: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 100
TABLE 50 FRANCE: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 101
TABLE 51 FRANCE: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 101
TABLE 52 FRANCE : GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 102
TABLE 53 FRANCE: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 102
TABLE 54 ROE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 103
TABLE 55 ROE: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 103
TABLE 56 ROE: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 104
TABLE 57 ROE: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 104
TABLE 58 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 106
TABLE 59 ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 106
TABLE 60 ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 107
TABLE 61 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 107
TABLE 62 ASIA PACIFIC: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 107
TABLE 63 CHINA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 109
TABLE 64 CHINA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 109
TABLE 65 CHINA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 109
TABLE 66 CHINA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 110
TABLE 67 INDIA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 111
TABLE 68 INDIA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 111
TABLE 69 INDIA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 112
TABLE 70 INDIA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 112
TABLE 71 JAPAN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 113
TABLE 72 JAPAN: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 114
TABLE 73 JAPAN: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 114
TABLE 74 JAPAN: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 115
TABLE 75 ROAPAC: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 116
TABLE 76 ROAPAC: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 116
TABLE 77 ROAPAC: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 116
TABLE 78 ROAPAC: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 117
TABLE 79 ROW: GENOMICS MARKET, BY REGION, 2017–2024 (USD MILLION) 119
TABLE 80 ROW: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 119
TABLE 81 ROW: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 119
TABLE 82 ROW: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 120
TABLE 83 ROW: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 120
TABLE 84 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 121
TABLE 85 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 122
TABLE 86 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 122
TABLE 87 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY END USER,
2017–2024 (USD MILLION) 123
TABLE 88 LATIN AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 124
TABLE 89 LATIN AMERICA: GENOMICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 124
TABLE 90 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 124
TABLE 91 LATIN AMERICA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 125
TABLE 92 PRODUCT LAUNCHES AND APPROVALS 128
TABLE 93 EXPANSIONS 128
TABLE 94 AGREEMENTS AND COLLABORATIONS 129
TABLE 95 ACQUISITIONS 129


LIST OF FIGURES

FIGURE 1 GENOMICS MARKET SEGMENTATION 18
FIGURE 2 GENOMICS MARKET: RESEARCH METHODOLOGY 20
FIGURE 3 RESEARCH DESIGN 21
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 24
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 27
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 27
FIGURE 7 DATA TRIANGULATION METHODOLOGY 28
FIGURE 8 GENOMICS MARKET, BY PRODUCT & SERVICE, 2018 30
FIGURE 9 GENOMICS MARKET, BY TECHNOLOGY, 2018 31
FIGURE 10 GENOMICS MARKET, BY APPLICATION, 2018 32
FIGURE 11 GENOMICS MARKET, BY END USER, 2018 33
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET 34
FIGURE 13 RISING GOVERNMENT FUNDING AND GROWTH IN THE NUMBER OF GENOMICS PROJECTS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 35
FIGURE 14 PCR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN GENOMICS MARKET IN 2018 36
FIGURE 15 CONSUMABLES SEGMENT COMMANDED THE LARGEST SHARE OF THE ASIA PACIFIC GENOMICS MARKET IN 2018 37
FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 38
FIGURE 17 CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE GENOMICS MARKET IN 2019 46
FIGURE 18 PCR SEGMENT WILL CONTINUE TO DOMINATE THE GENOMICS MARKET IN THE FORECAST PERIOD 54
FIGURE 19 DIAGNOSTIC APPLICATIONS TO DOMINATE THE GENOMICS MARKET DURING THE FORECAST PERIOD 63
FIGURE 20 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES TO COMMAND THE LARGEST SHARE OF THE GENOMICS MARKET IN 2019 74
FIGURE 21 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GENOMICS MARKET DURING THE FORECAST PERIOD 83
FIGURE 22 NORTH AMERICA: GENOMICS MARKET SNAPSHOT 85
FIGURE 23 EUROPE: GENOMICS MARKET SNAPSHOT 94
FIGURE 24 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT 105
FIGURE 25 ROW: GENOMICS MARKET SNAPSHOT 118
FIGURE 26 GENOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 126
FIGURE 27 COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET 131
FIGURE 28 COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET 135
FIGURE 29 ILLUMINA, INC.: COMPANY SNAPSHOT (2018) 136
FIGURE 30 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2017) 143
FIGURE 31 QIAGEN N.V.: COMPANY SNAPSHOT (2017) 148
FIGURE 32 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017) 154
FIGURE 33 AGILENT TECHNOLOGIES : COMPANY SNAPSHOT (2017) 157
FIGURE 34 ROCHE HOLDING AG: COMPANY SNAPSHOT (2017) 165
FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2017) 169
FIGURE 36 DANAHER CORPORATION: COMPANY SNAPSHOT (2017) 176
FIGURE 37 GENERAL ELECTRICAL COMPANY: COMPANY SNAPSHOT (2017) 179
FIGURE 38 EPPENDORF AG: COMPANY SNAPSHOT (2017) 183


★調査レポート[ゲノミクスの世界市場予測（～2024年）] ( Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024 / BT-2209) 販売に関する免責事項
[ゲノミクスの世界市場予測（～2024年）] ( Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024 / BT-2209) についてEメールでお問い合わせ
◆関連調査資料◆
  • miRNAシーケンシングおよびアッセイの世界市場予測（～2024年）
    BT 6953 / MarketsandMarkets / 2019年3月5日 / miRNAシーケンシングおよびアッセイの世界市場は、2018年の1億8,200万米ドルから2024年には3億3,400万米ドルに達し、この期間中11.2％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、ほかの技術と比較した場合のmiRNAシーケンシングの優位性、ゲノミクスへの研究資金の増加、シーケンシングコストの低減などが考えられます。一方で、熟練した専門家の不足により、この市場の成長は抑制される可能性があります。当調査レポートでは、miRNAシーケンシングおよびアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（ライブラリー作製、消耗品）分析、技術（合成によるシーケンシング、ナノポア計測、イオン半導体シーケンシング）分析、エンドユーザー（研究所、学術機関、CRO）分析、miRNAシーケンシングおよびアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The miRNA sequencing and assays market is expected to grow at a CAGR of 11.2% during the forecast period.”The miRNA sequencing and assays market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2%. The miRNA sequencing and assays market is driven by various factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing. However, the dearth of skilled professionals is expected to limit market growth to a certain extent. “The sequencing consumables segment held the dominant share...
  • レポーター遺伝子アッセイの世界市場予測（～2024年）
    BT-6990 / MarketsandMarkets / 2019年3月28日 / レポーター遺伝子アッセイの世界市場は、2018年の推定16億米ドルから2024年には26億米ドルに達し、この期間中10.1％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、細胞ベース研究に対する資金援助増加、遺伝子発現用途の拡大、および細胞ベースのアッセイの選好の高まりが考えられます。一方で、細胞生物学研究の高コストは、市場の成長を抑制すると予想されます。当調査レポートでは、レポーター遺伝子アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、試薬・アッセイキット（ルシフェラーゼ、緑色蛍光タンパク質、β-グルクロニダーゼ、β-ガラクトシダーゼ）分析、用途（遺伝子調節、タンパク質相互作用、細胞シグナル伝達経路）分析、エンドユーザー分析、レポーター遺伝子アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The reporter gene assays market is projected to grow at a CAGR of 10.1%.”The reporter gene assays market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2018, at a CAGR of 10.1%. Growth in this market is driven by increasing funding for cell-based research, the growing applications of gene expression, and a rising preference for cell-based assays. However, the high cost of cell biology research is expected to restrain the growth of this market to a certain extent during the forecast period. By end user, the academic and research institutes segment is...
  • 細胞単離/細胞分離の世界市場予測（～2024年）
    BT 2757 / MarketsandMarkets / 2019年2月28日 / 細胞単離/細胞分離の世界市場は、2019年の59億米ドルから2024年には130億米ドルに達し、この期間中17.2％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、がんや感染症を患っている患者数の増加、細胞ベースの研究への政府の資金援助の増加、技術の進歩、個別化医療への注目の高まりなどが考えられます。当調査レポートでは、細胞単離/細胞分離の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（試薬、ビーズ、遠心分離）分析、細胞のタイプ（ヒト、動物）分析、細胞源（骨髄、脂肪）分析、技術（ろ過）分析、細胞単離/細胞分離の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global cell isolation market is projected to register a CAGR of 17.2% during the forecast period.”The market size for cell isolation is expected to reach USD 13.0 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 17.2%. The growth in this market is attributed to the increasing number of patients suffering from cancer and infectious diseases, increasing government funding for cell-based research, technological advancements, and the growing focus on personalized medicine. “The bone marrow segment is estimated to grow rapidly during the forecast period.” By cell source, the cell isolation market is segmented into three...
  • 免疫沈降（IP）の世界市場予測（～2024年）
    BT 6910 / MarketsandMarkets / 2019年2月20日 / 免疫沈降の世界市場は、2018年の5億6,000万米ドルから2024年には7億5,000万米ドルに達し、この期間中5.0％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、ライフサイエンス業界における研究活動の増加と自己免疫疾患に関連する抗原を同定する（疾患メカニズムを理解し、これらの疾患を標的とする関連薬物を開発するための抗原抗体反応を用いる）必要性の高まりが考えられます。一方で、タンパク質精製のための代替技術の存在は市場の成長を妨げる可能性があります。当調査レポートでは、免疫沈降（IP）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（キット、試薬）分析、種類（単独IP、共免疫沈降、ChIP）分析、エンドユーザー（学術機関、研究機関、製薬会社・バイオテクノロジー企業）分析、免疫沈降（IP）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Increasing research activity in the life sciences industry is expected to drive the overall growth of the immunoprecipitation market.”The immunoprecipitation market is projected to reach USD 750 million by 2024 from USD 560 million in 2018, at CAGR of 5.0% during forecast period. The growth of this market is majorly driven by the increasing number of research activities in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases). However, the presence of alternative technologies for protein purification is expected to...
  • プロテオミクスの世界市場予測（～2024年）
    BT 2341 / MarketsandMarkets / 2019年2月28日 / プロテオミクスの世界市場は、2019年の195億米ドルから2024年には387億米ドルに達し、この期間中14.7％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、個別化医療や創薬の分野における研究活動の増加、製薬・バイオテクノロジー企業による研究開発費の増加、政府の資金援助、技術の進歩などが考えられます。さらには、精密医療におけるナノプロテオミクスや個別化されたプロテオミクスに注目が集まることも、この市場の成長の後押しとなっています。当調査レポートでは、プロテオミクスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、機器（分光法、クロマトグラフィー、電気泳動、マイクロフルイディクス、X線結晶解析）分析、試薬・サービス・ソフトウェア（タンパク質同定、キャラクタリゼーション、バイオインフォマティクス）分析、用途分析、プロテオミクスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The proteomics market is projected to grow at a CAGR of 14.1% during the forecast period (2019–2024).”The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%. An increase in the research activity, especially in the area of personalized medicine and drug discovery is the primary growth driver for this market. In addition, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and technological advancements are also propelling the growth of the proteomics market. The growing prominence of nanoproteomics and personalized proteomics for precision health...
  • ヘルスケアにおける相互運用性ソリューションの世界市場予測（～2024年）
    HIT-6989 / MarketsandMarkets / 2019年3月28日 / ヘルスケアにおける相互運用性ソリューションの世界市場は、2019年の推定23億米ドルから2024年には42億米ドルに達し、この期間中12.6％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、患者中心の医療への関心の高まり、医療費の増加を抑制するニーズの高まり、患者の治療と安全性を向上させるための政府の取り組み、ヘルスケア相互運用性に対する政府の資金援助、さらにはヘルスケアインフラの改善が考えられます。一方で、一貫したデータがないことで複雑さが増すこと、訓練を受けた医療IT専門家が不足していること、そしてデータのプライバシーに関する懸念は、市場が抱える課題です。当調査レポートでは、ヘルスケアにおける相互運用性ソリューションの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、タイプ（EHR相互運用性、健康情報交換、企業）分析、相互運用性レベル（基礎的、構造的、意味的）分析、エンドユーザー分析、ヘルスケアにおける相互運用性ソリューションの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global healthcare interoperability solutions market is projected to grow at a CAGR of 12.6%.”The healthcare interoperability solutions market is projected to reach USD 4.2 billion by 2024 from an estimated USD 2.3 billion in 2019, at a CAGR of 12.6%. The growing focus on patient-centric care delivery, rising need to curb increasing healthcare costs, government initiatives for enhancing patient care and safety, and government funding for healthcare interoperability are the primary growth factors for this market. The growing improvements in healthcare infrastructure are expected to offer significant growth opportunities for players in this market. However, increasing complexity with lack...
  • 暗号通貨の世界市場予測（～2024年）
    SE-5634 / MarketsandMarkets / 2018年10月22日 / MarketsandMarketsが発行した当調査レポートでは、暗号通貨の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、バリューチェーン分析、提供別（ハードウェア、ソフトウェア）分析、プロセス別（マイニング、トランザクション）分析、タイプ別分析、用途別（取引、送金、決済、電子商取引、小売）分析、暗号通貨の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Cryptocurrency market to grow at CAGR of 6.18% from 2019 to 2024”The cryptocurrency market is projected to reach USD 1.40 billion by 2024 from USD 1.03 billion by 2019, at a CAGR of 6.18% during the forecast period. Growth in this market can largely be attributed to factors such as transparency of distributed ledger technology, high remittances in developing countries, high cost of cross-border remittance, fluctuations in monetary regulations, and growth in venture capital investments. However, uncertain regulatory status, lack of awareness and technical understanding regarding cryptocurrency are expected to restrict the growth of the said market to a certain...
  • エキソソーム研究関連製品の世界市場予測（～2024年）
    BT 6939 / MarketsandMarkets / 2019年2月28日 / エキソソーム研究関連製品の世界市場は、2019年の9,100万米ドルから2024年には2億6,400万米ドルに達し、この期間中23.8％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、ライフサイエンス研究への資金提供の増加、がんの蔓延、およびエキソソームベースの治療への関心の高まりなどが考えられます。一方で、熟練した専門家の不足により、この市場の成長は抑制される可能性があります。当調査レポートでは、エキソソーム研究関連製品の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品・サービス（キット、試薬、機器、サービス）分析、用途（がん）分析、エンドユーザー（病院、学術機関、研究所）分析、エキソソーム研究関連製品の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“High global prevalence of cancer and increasing funding for life sciences are expected to drive the overall growth of the exosome research products market”The global exosome research products market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period. Factors driving the growth of this market include the increasing funding for life science research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this...
  • がん患者登録ソフトウェアの世界市場予測（～2024年）
    HIT-6993 / MarketsandMarkets / 2019年3月28日 / がん患者登録ソフトウェアの世界市場は、2019年の5,500万米ドルから2024年には9,100万米ドルに達し、この期間中10.4％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、がんの罹患率の増加、政府による積極的な取り組み、EHRの採用の増加、市販直後調査を目的としたがん患者登録データの利用増加、医療の質の向上、医療費削減に対する意識の高まりなどが考えられます。一方で、プライバシーとデータセキュリティ関連の懸念により、市場の成長は抑制される可能性があります。当調査レポートでは、がん患者登録ソフトウェアの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、タイプ（スタンドアロン型、統合型）分析、導入モード（オンプレミス、クラウド）分析、データベース（民間、公共）分析、機能性（がん報告、患者ケア、医学研究）分析、がん患者登録ソフトウェアの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Cancer patient registry software market projected to grow at a CAGR of 10.4%” The cancer patient registry software market is projected to reach USD 91 million by 2024 from USD 55 million in 2019, at a CAGR of 10.4%. Factors such as the growing prevalence of cancer, favorable government initiatives, rising adoption of EHRs, growing use of cancer patient registry data for post-marketing surveillance, and rising pressure to improve the quality of care and reduce healthcare costs are driving the growth of this market. However, privacy and data security-related concerns may restrain the growth of this market to a certain...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆